Other Stories

Johnson & Johnson starts phase three trial testing of COVID-19 vaccine candidate Updated: 2020-09-24 10:04:14 KST

American drugmaker Johnson and Johnson has begun its phase three trial of its COVID-19 vaccine candidate.
Johnson and Johnson is now the fourth drugmaker backed by the Trump administration to enter late-stage testing after Moderna, Pfizer and AstraZeneca.
Johnson and Johnson's trial will enroll up to 60-thousand adult volunteers across 215 locations in the U.S. and other countries.
The company expects possible vaccine batches for potential emergency use authorization to be available early next year.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.